Good morning. Elizabeth Cooney here again at STAT’s home in Boston, filling in for Ed Silverman who’s still in California, no doubt daydreaming about weekend plans. Some biopharma news to start the day:
After months of consideration, Louisiana officials are proceeding with plans for a “Netflix” payment model for obtaining hepatitis C treatments at an affordable price, STAT says. The state is seeking drug makers willing to supply treatments in return for subscription-based payments over five years for unlimited access to medication for anyone who is enrolled in the state Medicaid program or incarcerated in a state prison.